Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-16-078991
Filing Date
2016-09-06
Accepted
2016-09-06 18:25:41
Documents
1
Period of Report
2016-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4073
  Complete submission text file 0001140361-16-078991.txt   5435
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 3711 SOUTH MOPAC EXPRESSWAY, STE 100 AUSTIN TX 78746 512-901-0900
Mirna Therapeutics, Inc. (Issuer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MIRNA THERAPEUTICS, INC. 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address
Winkler Matthew (Reporting) CIK: 0001652067 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37566 | Film No.: 161871776